$FREVS
FIRST REAL ESTATE INVESTMENT TRUST OF NEW JERSEY Stock $frevs

$frevs Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-Q Financial Statement

#000117494724000354 Filed on March 15, 2024

Income Statement

Concept	2024 Q1
Revenue	$6.999M
YoY Change	0.29%
Cost Of Revenue	$4.981M
YoY Change	28.11%
Gross Profit	$2.018M
YoY Change	-34.71%
Gross Profit Margin	28.83%
Selling, General & Admin	$336.0K
YoY Change	3.07%
% of Gross Profit	16.65%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$725.0K
YoY Change	0.42%
% of Gross Profit	35.93%
Operating Expenses	$6.042M
YoY Change	22.41%
Operating Profit	$3.519M
YoY Change	-2.79%
Interest Expense	$1.842M
YoY Change	-1.81%
% of Operating Profit	52.34%
Other Income/Expense, Net
YoY Change
Pretax Income	$3.519M
YoY Change	-2.79%
Income Tax
% Of Pretax Income
Net Earnings	-$512.0K
YoY Change	-222.2%
Net Earnings / Revenue	-7.32%
Basic Earnings Per Share	-$0.07
Diluted Earnings Per Share	-$0.07
COMMON SHARES
Basic Shares Outstanding	7.450M shares
Diluted Shares Outstanding	7.450K shares

Balance Sheet

Concept	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$13.68M
YoY Change	-63.22%
Cash & Equivalents	$13.68M
Short-Term Investments
Other Short-Term Assets	$4.907M
YoY Change	62.59%
Inventory
Prepaid Expenses
Receivables	$819.0K
Other Receivables	$0.00
Total Short-Term Assets	$19.41M
YoY Change	-53.34%
LONG-TERM ASSETS
Property, Plant & Equipment	$93.90M
YoY Change	-2.22%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$17.57M
YoY Change	-6.18%
Other Assets	$305.0K
YoY Change	30.9%
Total Long-Term Assets	$130.3M
YoY Change	5.98%
TOTAL ASSETS
Total Short-Term Assets	$19.41M
Total Long-Term Assets	$130.3M
Total Assets	$149.7M
YoY Change	-9.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.362M
YoY Change	-4.49%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.995M
YoY Change	-2.85%
LONG-TERM LIABILITIES
Long-Term Debt	$129.2M
YoY Change	-6.25%
Other Long-Term Liabilities	$800.0K
YoY Change	77.38%
Total Long-Term Liabilities	$130.0M
YoY Change	-5.98%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.995M
Total Long-Term Liabilities	$130.0M
Total Liabilities	$133.0M
YoY Change	-5.91%
SHAREHOLDERS EQUITY
Retained Earnings	-$9.852M
YoY Change	55.64%
Common Stock	$74.00K
YoY Change	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$23.10M
YoY Change
Total Liabilities & Shareholders Equity	$149.7M
YoY Change	-9.01%

Cashflow Statement

Concept	2024 Q1
OPERATING ACTIVITIES
Net Income	-$512.0K
YoY Change	-222.2%
Depreciation, Depletion And Amortization	$725.0K
YoY Change	0.42%
Cash From Operating Activities	$934.0K
YoY Change	-208.35%
INVESTING ACTIVITIES
Capital Expenditures	$369.0K
YoY Change	-211.82%
Acquisitions
YoY Change
Other Investing Activities	$7.778M
YoY Change	-103.09%
Cash From Investing Activities	$7.409M
YoY Change	-2192.94%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$8.585M
YoY Change	-27.03%
NET CHANGE
Cash From Operating Activities	$934.0K
Cash From Investing Activities	$7.409M
Cash From Financing Activities	-$8.585M
Net Change In Cash	-$242.0K
YoY Change	-98.14%
FREE CASH FLOW
Cash From Operating Activities	$934.0K
Capital Expenditures	$369.0K
Free Cash Flow	$565.0K
YoY Change	-206.2%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital		usd
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-01-31
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	FIRST REAL ESTATE INVESTMENT TRUST OF NEW JERSEY, INC.
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	22-1697095
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	505 Main Street, Suite 400
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Hackensack
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	NJ
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	07601
CY2024Q1	dei	City Area Code CityAreaCode	(201)
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	488-6400
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	7449583	shares
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	92988000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	93617000	usd
CY2024Q1	us-gaap	Development In Process DevelopmentInProcess	908000	usd
CY2023Q4	us-gaap	Development In Process DevelopmentInProcess	898000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13679000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13217000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	16485000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	23593000	usd
CY2024Q1	us-gaap	Equity Method Investments EquityMethodInvestments	17573000	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	18137000	usd
CY2024Q1	us-gaap	Deposits Assets DepositsAssets	950000	usd
CY2023Q4	us-gaap	Deposits Assets DepositsAssets	962000	usd
CY2024Q1	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	661000	usd
CY2023Q4	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	690000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1094000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1090000	usd
CY2024Q1	us-gaap	Mortgage Loans On Real Estate Commercial And Consumer Net MortgageLoansOnRealEstateCommercialAndConsumerNet	158000	usd
CY2023Q4	us-gaap	Mortgage Loans On Real Estate Commercial And Consumer Net MortgageLoansOnRealEstateCommercialAndConsumerNet	559000	usd
CY2024Q1	frevsob	Fund Held In Postclosing Escrow FundHeldInPostclosingEscrow	281000	usd
CY2023Q4	frevsob	Fund Held In Postclosing Escrow FundHeldInPostclosingEscrow	883000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	4907000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	4912000	usd
CY2024Q1	frevsob	Deferred Charges Net DeferredChargesNet	305000	usd
CY2023Q4	frevsob	Deferred Charges Net DeferredChargesNet	311000	usd
CY2024Q1	frevsob	Interest Rate Swap Contracts InterestRateSwapContracts	806000	usd
CY2023Q4	frevsob	Interest Rate Swap Contracts InterestRateSwapContracts	1336000	usd
CY2024Q1	us-gaap	Assets Assets	149701000	usd
CY2023Q4	us-gaap	Assets Assets	159115000	usd
CY2024Q1	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	222000	usd
CY2023Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	222000	usd
CY2024Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	130235000	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	138179000	usd
CY2024Q1	us-gaap	Deferred Finance Costs Noncurrent Gross DeferredFinanceCostsNoncurrentGross	1051000	usd
CY2023Q4	us-gaap	Deferred Finance Costs Noncurrent Gross DeferredFinanceCostsNoncurrentGross	1117000	usd
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	129184000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	137062000	usd
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	1362000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	1275000	usd
CY2024Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	372000	usd
CY2023Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	372000	usd
CY2024Q1	us-gaap	Security Deposit Liability SecurityDepositLiability	1261000	usd
CY2023Q4	us-gaap	Security Deposit Liability SecurityDepositLiability	1262000	usd
CY2024Q1	us-gaap	Deferred Revenue DeferredRevenue	800000	usd
CY2023Q4	us-gaap	Deferred Revenue DeferredRevenue	668000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	132979000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	140639000	usd
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	20000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	20000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7449583	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7449583	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	74000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	74000	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	32075000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	32074000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-9852000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-8968000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	799000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1336000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	23096000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	24516000	usd
CY2024Q1	us-gaap	Minority Interest MinorityInterest	-6374000	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	-6040000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	16722000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	18476000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	149701000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	159115000	usd
CY2024Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	6454000	usd
CY2023Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	6222000	usd
CY2024Q1	frevsob	Tenant Reimbursement Revenue TenantReimbursementRevenue	458000	usd
CY2023Q1	frevsob	Tenant Reimbursement Revenue TenantReimbursementRevenue	646000	usd
CY2024Q1	frevsob	Other Real Estate Revenues OtherRealEstateRevenues	87000	usd
CY2023Q1	frevsob	Other Real Estate Revenues OtherRealEstateRevenues	111000	usd
CY2024Q1	us-gaap	Revenues Revenues	6999000	usd
CY2023Q1	us-gaap	Revenues Revenues	6979000	usd
CY2024Q1	frevsob	General Operating Expenses GeneralOperatingExpenses	3489000	usd
CY2023Q1	frevsob	General Operating Expenses GeneralOperatingExpenses	2450000	usd
CY2024Q1	us-gaap	Management Fee Expense ManagementFeeExpense	336000	usd
CY2023Q1	us-gaap	Management Fee Expense ManagementFeeExpense	326000	usd
CY2024Q1	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	1492000	usd
CY2023Q1	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	1438000	usd
CY2024Q1	us-gaap	Depreciation Depreciation	725000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	722000	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	6042000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	4936000	usd
CY2024Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	407000	usd
CY2023Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	189000	usd
CY2024Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-79000	usd
CY2023Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-243000	usd
CY2024Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-109000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-67000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	1842000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	1876000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-666000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	46000	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-154000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-373000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-512000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	419000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.06
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7450	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7424	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7450	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7433	shares
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-666000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	46000	usd
CY2024Q1	frevsob	Unrealized Loss Gain On Interest Rate Swap Contracts Before Reclassification UnrealizedLossGainOnInterestRateSwapContractsBeforeReclassification	-339000	usd
CY2023Q1	frevsob	Unrealized Loss Gain On Interest Rate Swap Contracts Before Reclassification UnrealizedLossGainOnInterestRateSwapContractsBeforeReclassification	-334000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Defined Benefit Plans Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToNoncontrollingInterest	191000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Defined Benefit Plans Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToNoncontrollingInterest	116000	usd
CY2024Q1	frevsob	Net Unrealized Gainloss On Interest Rate Cap And Swap Contracts NetUnrealizedGainlossOnInterestRateCapAndSwapContracts	-530000	usd
CY2023Q1	frevsob	Net Unrealized Gainloss On Interest Rate Cap And Swap Contracts NetUnrealizedGainlossOnInterestRateCapAndSwapContracts	-450000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-6000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax	-1000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-7000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-1203000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-404000	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-154000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-373000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1049000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-31000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	18476000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1000	usd
CY2024Q1	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	180000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-666000	usd
CY2024Q1	us-gaap	Dividends Common Stock DividendsCommonStock	372000	usd
CY2024Q1	frevsob	Net Unrealized Gainloss On Interest Rate Cap And Swap Contracts NetUnrealizedGainlossOnInterestRateCapAndSwapContracts	-530000	usd
CY2024Q1	frevsob	Net Unrealized Loss On Investment NetUnrealizedLossOnInvestment	-7000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	16722000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	24739000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	5000	usd
CY2023Q1	frevsob	Vested Share Units Issued To Consultant And Retired Directors VestedShareUnitsIssuedToConsultantAndRetiredDirectors	26000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1226000	usd
CY2023Q1	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	1850000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	46000	usd
CY2023Q1	us-gaap	Dividends Common Stock DividendsCommonStock	541000	usd
CY2023Q1	frevsob	Net Unrealized Gainloss On Interest Rate Cap And Swap Contracts NetUnrealizedGainlossOnInterestRateCapAndSwapContracts	-450000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	23201000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-666000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	46000	usd
CY2024Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-79000	usd
CY2023Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-243000	usd
CY2024Q1	us-gaap	Depreciation Depreciation	725000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	722000	usd
CY2024Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	181000	usd
CY2023Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	140000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	5000	usd
CY2023Q1	us-gaap	Paid In Kind Interest PaidInKindInterest	26000	usd
CY2024Q1	us-gaap	Loss On Sale Of Investments LossOnSaleOfInvestments	109000	usd
CY2023Q1	us-gaap	Loss On Sale Of Investments LossOnSaleOfInvestments	67000	usd
CY2024Q1	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	29000	usd
CY2023Q1	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	28000	usd
CY2024Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	45000	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-45000	usd
CY2024Q1	frevsob	Accreted Interest On Investment In Us Treasury Securities AccretedInterestOnInvestmentInUSTreasurySecurities	242000	usd
CY2023Q1	frevsob	Accreted Interest On Investment In Us Treasury Securities AccretedInterestOnInvestmentInUSTreasurySecurities	39000	usd
CY2024Q1	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	1000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-271000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-136000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	271000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2285000	usd
CY2024Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	132000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	94000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	934000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-862000	usd
CY2024Q1	frevsob	Cash Outlays Proceed From Sale Of Maryland Properties Net CashOutlaysProceedFromSaleOfMarylandPropertiesNet	66000	usd
CY2023Q1	frevsob	Cash Outlays Proceed From Sale Of Maryland Properties Net CashOutlaysProceedFromSaleOfMarylandPropertiesNet	165000	usd
CY2024Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	10596000	usd
CY2023Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	5673000	usd
CY2024Q1	us-gaap	Payments For Proceeds From Loans Receivable PaymentsForProceedsFromLoansReceivable	-17939000	usd
CY2024Q1	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	303000	usd
CY2023Q1	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	181000	usd
CY2024Q1	us-gaap	Payments For Leasing Costs PaymentsForLeasingCosts	20000	usd
CY2023Q1	us-gaap	Payments For Leasing Costs PaymentsForLeasingCosts	8000	usd
CY2024Q1	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	455000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	7409000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-6027000	usd
CY2024Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	7944000	usd
CY2023Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	393000	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1226000	usd
CY2024Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	89000	usd
CY2023Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	6000	usd
CY2024Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	372000	usd
CY2023Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	10742000	usd
CY2024Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	180000	usd
CY2023Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	1850000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-8585000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-11765000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-242000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-18654000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18356000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	58500000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18114000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	39846000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	1687000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	1728000	usd
CY2024Q1	us-gaap	Stock Issued1 StockIssued1	13000	usd
CY2023Q1	us-gaap	Stock Issued1 StockIssued1	78000	usd
CY2024Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	13000	usd
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	42000	usd
CY2024Q1	frevsob	Dividends Declared But Not Paid DividendsDeclaredButNotPaid	372000	usd
CY2023Q1	frevsob	Dividends Declared But Not Paid DividendsDeclaredButNotPaid	372000	usd
CY2024Q1	frevsob	Cash And Cash Equivalents CashAndCashEquivalents	13679000	usd
CY2023Q1	frevsob	Cash And Cash Equivalents CashAndCashEquivalents	31514000	usd
CY2024Q1	frevsob	Tenants Security Accounts TenantsSecurityAccounts	950000	usd
CY2023Q1	frevsob	Tenants Security Accounts TenantsSecurityAccounts	1024000	usd
CY2024Q1	frevsob	Funds Held In Postclosing Escrow FundsHeldInPostclosingEscrow	-281000	usd
CY2023Q1	frevsob	Funds Held In Postclosing Escrow FundsHeldInPostclosingEscrow	-5962000	usd
CY2024Q1	us-gaap	Escrow Deposits Related To Property Sales EscrowDepositsRelatedToPropertySales	3204000	usd
CY2023Q1	us-gaap	Escrow Deposits Related To Property Sales EscrowDepositsRelatedToPropertySales	1346000	usd
CY2024Q1	frevsob	Total Cash Cash Equivalents And Restricted Cash TotalCashCashEquivalentsAndRestrictedCash	18114000	usd
CY2023Q1	frevsob	Total Cash Cash Equivalents And Restricted Cash TotalCashCashEquivalentsAndRestrictedCash	39846000	usd
CY2024Q1	us-gaap	Dividends Payable Amount Per Share DividendsPayableAmountPerShare	0.05
CY2024Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	9000	shares
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	8440	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2024Q1	frevsob	Net Unrealized Gainloss On Interest Rate Cap And Swap Contracts NetUnrealizedGainlossOnInterestRateCapAndSwapContracts	-530000	usd
CY2023Q1	frevsob	Net Unrealized Gainloss On Interest Rate Cap And Swap Contracts NetUnrealizedGainlossOnInterestRateCapAndSwapContracts	-450000	usd
CY2024Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	109000	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	67000	usd
CY2024Q1	frevsob	Percentage Of Management Fees Of Rent Collected PercentageOfManagementFeesOfRentCollected	0.05	pure
CY2024Q1	us-gaap	Other Additional Capital OtherAdditionalCapital	3420000	usd
CY2024Q1	us-gaap	Interest Expense Federal Funds Purchased InterestExpenseFederalFundsPurchased	3420000	usd
CY2024Q1	us-gaap	Custody Fees CustodyFees	3420000	usd
CY2024Q1	us-gaap	Legal Fees LegalFees	314000	usd
CY2023Q1	us-gaap	Legal Fees LegalFees	196000	usd
CY2024Q1	us-gaap	Significant Purchase Commitment Description SignificantPurchaseCommitmentDescription	This sale resulted in net proceeds of approximately $58.7 million (inclusive of approximately $0.5 million in funds released from the Maryland Purchaser Escrow Payment for the three months ended January 31, 2024), after payment of related mortgage debt in the amount of $155.8 million and the corresponding swap breakage fees of approximately $213,000 related to the early termination of the interest rate swap contracts on the Damascus Property loan, payment of loans (including interest) to each of the equity owners in Grande Rotunda in the amount of approximately $31 million and certain transactional expenses and transfer taxes including brokerage fees due to Hekemian & Co. of approximately $6.4 million (see Note 8 for additional details). As of January 31, 2024, approximately $7,084,000 of the Maryland Purchaser Escrow Payment has been released from escrow to the Maryland Sellers. The escrow and related gain on sale were reduced by approximately $0.1 million and $0.2 million for the three months ended January 31, 2024 and 2023, respectively, due to a change in estimate related to a change in the timing of anticipated rent commencement dates for certain tenants, which will reduce the escrowed funds available to be released to Grande Rotunda. Approximately $0.3 million and $0.9 million of remaining funds are held in a post-closing escrow for rents and are included in “Funds held in post-closing escrow” on the accompanying condensed consolidated balance sheets as of January 31, 2024 and October 31, 2023, respectively. These funds held in post-closing escrow are anticipated to be released by the end of Fiscal 2025. The sale of the Maryland Properties resulted in a net gain of approximately $67.7 million (as adjusted) (with a consolidated impact to FREIT of approximately $45 million) which includes approximately $7.4 million of proceeds released and anticipated to be released from funds held in escrow, a write-off of the straight-line rent receivable of approximately $2.9 million and a write-off of unamortized lease commissions of approximately $1.7 million.
CY2022Q3	frevsob	Non Recurring Cash Distribution Per Share NonRecurringCashDistributionPerShare	7.5
CY2023Q3	us-gaap	Dividends Payable Amount Per Share DividendsPayableAmountPerShare	0.25
CY2023Q3	us-gaap	Dividends Payable Amount Per Share DividendsPayableAmountPerShare	0.3
CY2024Q1	us-gaap	Payment For Management Fee PaymentForManagementFee	13400000	usd
CY2023Q1	us-gaap	Payment For Management Fee PaymentForManagementFee	0	usd
CY2023Q4	us-gaap	Repayments Of Debt RepaymentsOfDebt	9000000	usd
CY2023Q4	frevsob	Mortgage Loans On Real Estate Extended Amount MortgageLoansOnRealEstateExtendedAmount	7500000	usd
CY2024Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	7500000	usd
CY2023Q3	us-gaap	Derivative Fixed Interest Rate DerivativeFixedInterestRate	0.0605	pure
CY2024Q1	us-gaap	Derivative Variable Interest Rate DerivativeVariableInterestRate	0.0921	pure
CY2024Q1	us-gaap	Derivative Fixed Interest Rate DerivativeFixedInterestRate	0.0605	pure
CY2024Q1	frevsob	Fixed Interest Rate FixedInterestRate	0.075	pure
CY2024Q1	us-gaap	Loans Payable LoansPayable	157347	usd
CY2023Q4	frevsob	Principal Amount PrincipalAmount	1888166	usd
CY2024Q1	frevsob	Annual Debt Service Saving AnnualDebtServiceSaving	0.085	pure
CY2024Q1	us-gaap	Escrow Deposit EscrowDeposit	112556	usd
CY2024Q1	us-gaap	Replacement Reserve Escrow ReplacementReserveEscrow	2000722	usd
CY2024Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	13000000	usd
CY2023Q4	us-gaap	Line Of Credit Facility Current Borrowing Capacity LineOfCreditFacilityCurrentBorrowingCapacity	13000000	usd
CY2024Q1	frevsob	Fair Value Of Per Share FairValueOfPerShare	125700000
CY2023Q4	frevsob	Fair Value Of Per Share FairValueOfPerShare	130800000
CY2024Q1	frevsob	Carrying Value Net Price Per Share CarryingValueNetPricePerShare	129200000
CY2023Q4	frevsob	Carrying Value Net Price Per Share CarryingValueNetPricePerShare	137100000
CY2024Q1	frevsob	Real Estate Rental Revenue RealEstateRentalRevenue	7028000	usd
CY2023Q1	frevsob	Real Estate Rental Revenue RealEstateRentalRevenue	7007000	usd
CY2024Q1	us-gaap	Other Expense From Real Estate Partnership Operations OtherExpenseFromRealEstatePartnershipOperations	3509000	usd
CY2023Q1	us-gaap	Other Expense From Real Estate Partnership Operations OtherExpenseFromRealEstatePartnershipOperations	3387000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	3519000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	3620000	usd
CY2024Q1	frevsob	Recurring Capital Improvements RecurringCapitalImprovements	96000	usd
CY2023Q1	frevsob	Recurring Capital Improvements RecurringCapitalImprovements	145000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3519000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3620000	usd
CY2024Q1	us-gaap	Straight Line Rent Adjustments StraightLineRentAdjustments	29000	usd
CY2023Q1	us-gaap	Straight Line Rent Adjustments StraightLineRentAdjustments	28000	usd
CY2024Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	407000	usd
CY2023Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	189000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1808000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	827000	usd
CY2024Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-109000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-67000	usd
CY2024Q1	us-gaap	Depreciation Nonproduction DepreciationNonproduction	725000	usd
CY2023Q1	us-gaap	Depreciation Nonproduction DepreciationNonproduction	722000	usd
CY2024Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-79000	usd
CY2023Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-243000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	1842000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	1876000	usd
CY2024Q1	us-gaap	Net Income Loss Allocated To Limited Partners NetIncomeLossAllocatedToLimitedPartners	-666000	usd
CY2023Q1	us-gaap	Net Income Loss Allocated To Limited Partners NetIncomeLossAllocatedToLimitedPartners	46000	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-154000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-373000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-512000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	419000	usd
CY2023Q1	frevsob	Cash Compensation CashCompensation	20000	usd
CY2023Q1	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	15.5
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Maximum Number Of Shares Per Employee ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee	1290	shares
CY2023Q1	us-gaap	Shares Issued SharesIssued	1290	shares
CY2024Q1	us-gaap	Deferred Compensation Arrangement With Individual Compensation Expense DeferredCompensationArrangementWithIndividualCompensationExpense	1000	usd
CY2023Q1	us-gaap	Deferred Compensation Arrangement With Individual Compensation Expense DeferredCompensationArrangementWithIndividualCompensationExpense	5000	usd
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	112900	usd
CY2023Q1	frevsob	Aggregate Amount AggregateAmount	1200000	usd
CY2024Q1	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	274509	shares
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	274509	shares
CY2024Q1	frevsob	Years Minimum Term Range Of Residentiall Leases YearsMinimumTermRangeOfResidentiallLeases	P5Y
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear	4909000	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	4095000	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	3212000	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	2024000	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received Four Years LessorOperatingLeasePaymentsToBeReceivedFourYears	1024000	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received Thereafter LessorOperatingLeasePaymentsToBeReceivedThereafter	3197000	usd
CY2024Q1	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	18461000	usd
CY2024Q1	us-gaap	Deferred Compensation Arrangement With Individual Exercise Price DeferredCompensationArrangementWithIndividualExercisePrice	95
CY2023Q2	us-gaap	Area Of Land AreaOfLand	84254	sqft
CY2024Q1	us-gaap	Amortization Expense Per Physical Unit Of Production AmortizationExpensePerPhysicalUnitOfProduction	4
CY2024Q1	us-gaap	Payments For Rent PaymentsForRent	336720	usd
CY2024Q1	frevsob	Lease Years LeaseYears	P14Y
CY2023Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax		usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax		usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax		usd
CY2024Q1	us-gaap	Paid In Kind Interest PaidInKindInterest		usd
CY2023Q1	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets		usd
CY2023Q1	us-gaap	Payments For Proceeds From Loans Receivable PaymentsForProceedsFromLoansReceivable		usd
CY2024Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
CY2024Q1	us-gaap	Line Of Credit Facility Current Borrowing Capacity LineOfCreditFacilityCurrentBorrowingCapacity		usd
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--10-31
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000036840

Files In Submission

Name	View Source	Status
0001174947-24-000354-index-headers.html	Edgar Link	pending
0001174947-24-000354-index.html	Edgar Link	pending
0001174947-24-000354.txt	Edgar Link	pending
0001174947-24-000354-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
frevsob-20240131.htm	Edgar Link	pending
frevsob-20240131.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
frevsob-20240131_cal.xml	Edgar Link	unprocessable
frevsob-20240131_def.xml	Edgar Link	unprocessable
frevsob-20240131_lab.xml	Edgar Link	unprocessable
frevsob-20240131_pre.xml	Edgar Link	unprocessable
frevsob-20240131_htm.xml	Edgar Link	completed
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$FREVS
FIRST REAL ESTATE INVESTMENT TRUST OF NEW JERSEY Stock $frevs

2024 Q1 Form 10-Q Financial Statement

#000117494724000354 Filed on March 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FREVS FIRST REAL ESTATE INVESTMENT TRUST OF NEW JERSEY Stock $frevs

2024 Q1 Form 10-Q Financial Statement

#000117494724000354 Filed on March 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FREVS
FIRST REAL ESTATE INVESTMENT TRUST OF NEW JERSEY Stock $frevs